Cholesterol monitors industry expected to cross US$ 5 million by 2033

New Delhi: In 2023, the cholesterol monitors market is anticipated to be valued at US$ 2,660.3 million. The cholesterol monitors industry is expected to expand at a 7.3% CAGR from 2023 to 2033 and is likely to generate US$ 5,379.2 million.

Rising rates of obesity and an aging population in developed nations like the United States, Germany, and France have increased the cases of patients with high levels of bad cholesterol, necessitating a daily rise in the need for cholesterol monitoring kits worldwide.

The global cholesterol monitor market is likely to expand due to the rising popularity of non-invasive technologies for cholesterol monitoring.

Statistical Estimation in the Global Cholesterol Monitors Market

A significant factor surging the increase in demand for cholesterol monitor kits is the aging population. The population division of the Department of Economic and Social Affairs projects that by 2050, there are likely to be 21.1% more people in the world who are 60 years of age or older than in 1990 (9.2% to 11.7%).

According to data from the United Health Foundation from 2017, 12.5% of adults 60 and older had elevated total cholesterol. Such a high prevalence is anticipated to fuel cholesterol monitor market expansion soon.

Since high cholesterol has no symptoms, comprehensive cholesterol testing is required. These tests evaluate the levels of triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and total cholesterol in the blood. Measurements of blood cholesterol help to reduce the risk of peripheral artery disease, heart attack, and stroke.

Cholesterol levels should be tested if a person has been diagnosed with a stroke, PAD, coronary heart disease, family history of early CVD, overweight, diabetes, cholesterol-related condition, or high blood pressure. As per the Centers for Disease Control and Prevention, 1 in 6 adults (16.3%) of the population has high cholesterol (which is defined as 240 mg/dL or higher).

Expanding Healthcare Infrastructure in Emerging Economies Propels the Cholesterol Monitors Industry

The increasing prevalence of cardiovascular disorders, coupled with a growing emphasis on early diagnosis and miniaturization of cholesterol monitors, is expected to drive the growth of the global cholesterol monitors market. The preference for self-monitoring to enhance the quality of life and lead a healthy lifestyle is another factor driving the expansion of the market.

The market is likely to expand due to the increased focus on reducing the burden of cardiovascular diseases (CVDs) worldwide and initiatives for preventive healthcare practices like screening and health check-up programs.

The development of the global cholesterol monitors market is also aided by governmental changes that provide state-of-the-art healthcare facilities and awareness campaigns that are likely to raise the standard of testing.

Barriers Impacting the Cholesterol Monitors Market

The absence of awareness regarding health benefits linked with lipid testing for food and beverages in emerging economies such as Bangladesh, Africa, and Afghanistan is likely to restrict the cholesterol monitors market growth throughout the forecast period.

The major factors preventing the market growth of cholesterol monitors are the need for healthcare resources, an undertrained workforce, strict safety regulations, and a lack of food safety infrastructure in the northern regions of Asia Pacific and the north and middle of Africa.

Cholesterol Monitors: Navigating the Landscape from 2018 to the Roaring 2033

The cholesterol monitors market experienced significant growth from 2018 to 2022, driven by rising cardiovascular health awareness. Technological advancements led to more accurate and user-friendly devices, fostering market expansion.

The period from 2023 to 2033 is anticipated to witness a booming era for cholesterol monitors. Innovations like portable, connected devices and personalized health management solutions may force sustained market growth. Increasing adoption of preventive healthcare, coupled with a growing aging population, may fuel demand. Regulatory support and emphasis on telehealth services may propel market expansion for cholesterol monitors.

Integrating artificial intelligence and data analytics into cholesterol monitoring systems to revolutionize patient care. The market’s transformation beyond growth can be characterized by enhanced accessibility, precision, and integration within broader healthcare ecosystems.

Regional Outlook

Healthcare Innovations: North America’s Surging Demand for Cholesterol Monitoring

North America dominates the global cholesterol monitors market, accounting for 35.3% in 2023. This market growth is primarily due to the rise in the incidence of CVDs, the rapidly aging population, the high preference for self-monitoring devices, and increased awareness related to the region’s prevention and early diagnosis of diseases.

According to the Centers for Disease Control and Prevention, nearly 1 in 2 Americans have high cholesterol, i.e., almost 38% of American adults (total blood cholesterol ≥ 200 mg/dL).1 Too much cholesterol puts you at risk for heart disease and stroke, two leading causes of death in the United States.

Owing to the increased risk of high cholesterol and its asymptomatic nature, the need for cholesterol monitors is incessant in the region. The prevalence of heart diseases and obesity in the region is a major concern.

The United Health Foundation’s annual report revealed that the obesity rate increased from 31.5% in 2021 to 30.4% in 2020 in the United States. This, in turn, the mounting preference for preventive healthcare is also anticipated to drive regional growth. Rising awareness and initiatives from the government and several healthcare organizations are expected to propel market growth.

European Consumers Prioritize Heart Health, Triggering Cholesterol Monitor Boom

Europe is the second-leading region, accounting for 28.3% of the cholesterol monitors market share in 2023. The region is likely to maintain its projected growth over the forecast period, revealing Future Market Insights.

Weight problems and obesity are snowballing rapidly across the European Union, with estimates of nearly 53% of adult problems and obesity was snowballing quickly across the European Union populace overweight in 2020. Obesity significantly increases the risk of chronic diseases like cardiovascular disease, type-2 diabetes, and hypertension. Along with this, it is a major cause of rising cases of bad cholesterol in the Europe region.

According to the World Health Organization, nearly 54% of European men and women, the highest percentage for any region worldwide, are affected by ‘bad’ cholesterol. Besides, approximately 133.3 million people in the five largest states (Germany, France, Italy, Spain, and the United Kingdom) suffer from high levels of bad cholesterol.

The government in several countries is trying to increase the testing and make certain guidelines to direct people towards awareness of bad cholesterol. Prominent cholesterol monitor manufacturers are developing novel technologies and innovative testing kits to make cholesterol level testing easier and cheaper. Owing to the factors mentioned earlier, the region offers a pool of growth prospects to the key players.

Competitive Landscape

Key cholesterol monitors manufacturers have entered into merger agreements to expand their portfolios and provide effective services that can assist in managing infectious diseases and uncontrollable cholesterol levels.

Prominent Cholesterol Monitors Manufacturers

·         Roche Diagnostics

·         PTS Diagnostics

·         Omron Healthcare, Inc.

·         ACON Laboratories, Inc.

·         AccuTech

·         LLC

·         Alere Inc.

·         Siemens

·         Medline Industries, Inc.

·         Abaxis, Inc.

·         ManthaMed

·         Fisher Scientific

These insights are based on a report Cholesterol Monitors Market by Future Market Insights.